Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) FCF Margin (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of FCF Margin data on record, last reported at 904.07% in Q3 2025.

  • For Q3 2025, FCF Margin fell 23745.0% year-over-year to 904.07%; the TTM value through Sep 2025 reached 741.06%, up 18000.0%, while the annual FY2024 figure was 604.77%, 80999.0% up from the prior year.
  • FCF Margin reached 904.07% in Q3 2025 per TNXP's latest filing, down from 768.77% in the prior quarter.
  • Across five years, FCF Margin topped out at 449.14% in Q2 2024 and bottomed at 904.07% in Q3 2025.
  • Average FCF Margin over 3 years is 675.51%, with a median of 682.79% recorded in 2025.
  • Peak YoY movement for FCF Margin: soared 13585bps in 2024, then crashed -31963bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 744.0% in 2023, then grew by 24bps to 566.73% in 2024, then crashed by -60bps to 904.07% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 904.07% in Q3 2025, 768.77% in Q2 2025, and 682.79% in Q1 2025.